Skip to main content
Advertisement
Advertisement

MGNX

MGNX logo

MacroGenics, Inc.

4.06
USD
Sponsored
+0.06
+1.52%
Sep 14, 10:38 UTC -4
Open

MGNX Earnings Reports

Positive Surprise Ratio

MGNX beat 19 of 43 last estimates.

44%

Next Report

Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$40.25M
/
-$0.05
Implied change from Q2 26 (Revenue/ EPS)
+22.60%
/
-80.77%
Implied change from Q3 25 (Revenue/ EPS)
-44.74%
/
-118.52%

MacroGenics, Inc. earnings per share and revenue

On Aug 13, 2026, MGNX reported earnings of -0.26 USD per share (EPS) for Q2 26, missing the estimate of -0.12 USD, resulting in a -102.65% surprise. Revenue reached 32.83 million, compared to an expected 68.80 million, with a -52.28% difference. The market reacted with a +3.43% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 40.25 million USD, implying an decrease of -80.77% EPS, and increase of 22.60% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Medtronic plc
Report Date
Sep 01, 2026 For Q1 27
Estimate
$1.40
Actual
$1.45
Surprise
+3.45%
FAQ
For Q2 2026, MacroGenics, Inc. reported EPS of -$0.26, missing estimates by -102.65%, and revenue of $32.83M, -52.28% below expectations.
The stock price moved up 3.43%, changed from $4.08 before the earnings release to $4.22 the day after.
The next earning report is scheduled for Nov 10, 2026.
Based on 6 analysts, MacroGenics, Inc. is expected to report EPS of -$0.05 and revenue of $40.25M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement